Sorrento Therape Stock Working Capital
| SRNE Stock | USD 0 0.0007 28.00% |
Sorrento Therape fundamentals help investors to digest information that contributes to Sorrento Therape's financial success or failures. It also enables traders to predict the movement of Sorrento OTC Stock. The fundamental analysis module provides a way to measure Sorrento Therape's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sorrento Therape otc stock.
Sorrento |
Sorrento Therape OTC Stock Working Capital Analysis
Sorrento Therape's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Sorrento Therape Working Capital | (231.55 M) |
Most of Sorrento Therape's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sorrento Therape is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
Based on the company's disclosures, Sorrento Therape has a Working Capital of (231.55 Million). This is 154.4% lower than that of the Biotechnology sector and 142.99% lower than that of the Health Care industry. The working capital for all United States stocks is 115.66% higher than that of the company.
Sorrento Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sorrento Therape's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Sorrento Therape could also be used in its relative valuation, which is a method of valuing Sorrento Therape by comparing valuation metrics of similar companies.Sorrento Therape is currently under evaluation in working capital category among its peers.
Sorrento Fundamentals
| Return On Equity | -3.79 | |||
| Return On Asset | -0.41 | |||
| Operating Margin | (5.11) % | |||
| Current Valuation | 129.17 M | |||
| Shares Outstanding | 551.28 M | |||
| Shares Owned By Insiders | 0.80 % | |||
| Shares Owned By Institutions | 0.03 % | |||
| Number Of Shares Shorted | 64.56 M | |||
| Price To Earning | 41.15 X | |||
| Price To Book | 4.01 X | |||
| Price To Sales | 0.03 X | |||
| Revenue | 62.84 M | |||
| Gross Profit | (167.05 M) | |||
| EBITDA | (364.52 M) | |||
| Net Income | (577.76 M) | |||
| Cash And Equivalents | 133.6 M | |||
| Cash Per Share | 0.30 X | |||
| Total Debt | 134.5 M | |||
| Debt To Equity | 1.51 % | |||
| Current Ratio | 1.35 X | |||
| Book Value Per Share | (0.38) X | |||
| Cash Flow From Operations | (293.86 M) | |||
| Short Ratio | 4.96 X | |||
| Earnings Per Share | (1.10) X | |||
| Price To Earnings To Growth | (0.07) X | |||
| Target Price | 13.0 | |||
| Number Of Employees | 949 | |||
| Beta | 1.84 | |||
| Market Capitalization | 2.21 M | |||
| Total Asset | 472.84 M | |||
| Retained Earnings | (1.96 B) | |||
| Working Capital | (231.55 M) | |||
| Current Asset | 71.84 M | |||
| Current Liabilities | 36.04 M | |||
| Net Asset | 472.84 M |
About Sorrento Therape Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sorrento Therape's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sorrento Therape using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sorrento Therape based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Sorrento OTC Stock
Sorrento Therape financial ratios help investors to determine whether Sorrento OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sorrento with respect to the benefits of owning Sorrento Therape security.